share_log

Illumina | 8-K: Current report

Illumina | 8-K: Current report

Illumina | 8-K：重大事件
美股SEC公告 ·  2024/06/04 05:27

Moomoo AI 已提取核心信息

Illumina's board has approved the spin-off of GRAIL, with the distribution scheduled for June 24, 2024. Shareholders will receive one GRAIL share for every six Illumina shares held as of June 13, 2024. GRAIL will begin trading on Nasdaq under "GRAL" symbol on June 25, 2024, with Illumina distributing at least 85.5% of GRAIL's common stock.The company expects to incur charges of $35-50 million, primarily for legal and advisory fees related to the spin-off, with most expenses occurring in Q2 2024. The spin-off approval triggers a potential goodwill impairment test in Q2 2024. As of March 31, 2024, GRAIL-related assets include $1.47B in goodwill, $561M in non-amortizing R&D, and $2.09B in amortizing intangible assets.The distribution requires no shareholder vote or payment, though investors are advised to consult financial advisors regarding trading implications. Prior to the spin-off, GRAIL, LLC will be converted to GRAIL, Inc., a Delaware corporation. The distribution remains subject to conditions outlined in GRAIL's Form 10 registration statement.
Illumina's board has approved the spin-off of GRAIL, with the distribution scheduled for June 24, 2024. Shareholders will receive one GRAIL share for every six Illumina shares held as of June 13, 2024. GRAIL will begin trading on Nasdaq under "GRAL" symbol on June 25, 2024, with Illumina distributing at least 85.5% of GRAIL's common stock.The company expects to incur charges of $35-50 million, primarily for legal and advisory fees related to the spin-off, with most expenses occurring in Q2 2024. The spin-off approval triggers a potential goodwill impairment test in Q2 2024. As of March 31, 2024, GRAIL-related assets include $1.47B in goodwill, $561M in non-amortizing R&D, and $2.09B in amortizing intangible assets.The distribution requires no shareholder vote or payment, though investors are advised to consult financial advisors regarding trading implications. Prior to the spin-off, GRAIL, LLC will be converted to GRAIL, Inc., a Delaware corporation. The distribution remains subject to conditions outlined in GRAIL's Form 10 registration statement.
生物技术公司illumina宣布其子公司GRAIL的Spin-Off获得公司董事会批准。这项Spin-Off将导致至少85.5%的GRAIL普通股以比例红利形式分配给Illumina的股东。该分配计划于2024年6月24日纽约市时间上午12:01生效，预计GRAIL将在随后的一天以GRAL为股票代码在纳斯达克全球精选市场上交易。截至股权登记日期2024年6月13日，Illumina的股东每持有6股Illumina股票将获得1股GRAIL股票。Spin-Off取决于GRAIL在SEC提交的10号表格中所概述的某些条件。在Spin-Off方面，Illumina预计将承担3500万至5000万美元的...展开全部
生物技术公司illumina宣布其子公司GRAIL的Spin-Off获得公司董事会批准。这项Spin-Off将导致至少85.5%的GRAIL普通股以比例红利形式分配给Illumina的股东。该分配计划于2024年6月24日纽约市时间上午12:01生效，预计GRAIL将在随后的一天以GRAL为股票代码在纳斯达克全球精选市场上交易。截至股权登记日期2024年6月13日，Illumina的股东每持有6股Illumina股票将获得1股GRAIL股票。Spin-Off取决于GRAIL在SEC提交的10号表格中所概述的某些条件。在Spin-Off方面，Illumina预计将承担3500万至5000万美元的费用，主要是法律和咨询费用，大部分在2024年Q2期间出现，剩余部分在Q3期间出现。此外，Spin-Off可能导致Illumina的潜在商誉减值，该减值可能在2024年Q2的中期测试后被确认。截至2024年3月31日，该公司的资产负债表显示了14.66亿美元的商誉，5.61亿美元的未摊销进程研究和开发费用，以及20.92亿美元的与GRAIL相关的净摊销无形资产。

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    燃石医学
    BNR
    -- 6.940
    Neuronetics
    STIM
    -- 4.360
    Personalis
    PSNL
    -- 5.510
    OncoCyte
    OCX
    -- 2.5600
    恩佐生化
    ENZ
    -- 0.545
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    科技巨头财报季如火如荼，英伟达压轴会表现如何？
    星期四， $亚马逊 (AMZN.US)$ 股价在公司报告第四季度调整后每股收益为1.86美元，预估为每股1.50美元，营业收入为1877.9亿，预估为1873.2亿后下跌。该公司预测第一季度的营业收入数字低于华尔街的预期，预测本季度最多为1550亿，而分析师希望为1580亿。 星 展开
    亚马逊盈利预告：猜测开盘价，获取奖励！